 |
|
  |
|
May 2006 |
Science in India Newsletter
|
|
Science & Technology Newsletter India – May 2006 |
|
 |
|
|
|
Index
S&T Policies:
1. Research and development outsourced
to India
2. India to double investment in Science and Technology
3. S&T initiatives 2006
4. NSEF - new funding mechanism
5. Grant for IISc by Finance minister
6. Kapil Sibal releases report on Indian Semiconductor Industry
7. India and South Korea sign MoU for S&T cooperation
8. Guidelines on stem cell research
Research:
9.
India-Biotechnology Power
10. Bio-Asia 2006
11. Bangalore Bio 07.-09-06.2006
12. Tuberculosis breakthrough
13. Indian scientists make a quantum jump
14. Meningitis vaccine successful in phase I clinical trial
15. Indian Scientists announce new reactor concept
16. Indian satellite can identify quake prone regions
17. Scientists culture foetal nervous system cells
18. Genetic link to arsenic-related disease found
Academic Exchange/ Education:
19. Science and Technology education in
India 20. Increase of Indian students to UK
21. IITs expanding
22. Upgrade of NITs
23. MoU with US for joint research
24. Joint research programs between Japan and NCBS
25. Nanoelectronics Centre of Excellence at IIT and IISC
26. Meeting of Nobel Laureates and students in chemistry
27. First Max Planck India Workshop on Economics
28. Fellowship package
29. Wolverhampton University office in Delhi
Miscellaneous:
30. Nasscom to enhance focus on the
domestic IT market
31. Two Indian scientists elected to ICSU
32. Dr Reddy's Lab buys Germany's Betapharm
|
|
1. Research and development outsourced to
India
A new report from the Indian government's Technology
Information Forecasting and Assessment Council (TIFAC), has
illustrated the extent to which India is becoming a more
important player in Research and Development (R&D), with new
figures on Foreign Direct Investment (FDI) in R&D. The report
states that 1.13 billion USD flowed into India during the
five-year period of 1998 to 2003. Some of this money came from
Europe, most notably from Germany, which is the second largest
joint investor in India, but also from France, Denmark and the
UK. The largest investor is the US, while money has also come
from Japan and China. This suggests that some of the
investment that was coming into Europe, for example from the
US, is now going to India. The report states that nearly half
of the companies created through FDI in India have been
established due to relocation of in-house R&D. Most FDI is
going towards computer-based R&D, followed by pharmaceuticals,
automotive, chemicals and agricultural research. India's draws
include the availability and price of the country's workforce.
(To read more please visit:
http://www.tifac.org.in/)

According to Prime Minister
Manmohan Singh the Centre would double the investment in
science and technology to around two per cent of GDP. One of
the best investments is to concentrate on enhancing manpower
development in science and technology and provide the
institutions with best facilities and faculty. Development of
grid technology linking Indian institutions and foreign
partners would revolutionise communications, Singh said,
adding that Indian scientists and teachers will be a part of a
networked community, interconnected with each other and the
rest of the world.
(PTI Science Service, 1.-15.12.2005)

|
|
-
the Council for Scientific
and Industrial Research (CSIR), New Delhi, would be given
the status of a Deemed University as well as greater
autonomy for bolder initiatives for public-private
partnerships and investing knowledge as equity
-
a national biotechnology
development strategy with 50 centers of excellence and 500
research positions for life sciences and biotechnology
-
a legislation on
Intellectual Property Rights (IPR) to ensure inventors and
organisations a return for their innovative efforts
-
setting up of a board of
science and engineering research and a pool of 1000
scientific positions in India and abroad at different
laboratories
(PTI, Science Service, 16.-31.01.2006)

|
|
The Science and Technology
Ministry (DST) has proposed a new funding mechanism, under
which scientists will sanction funds. The National Science and
Engineering Foundation (NSEF), with a corpus of 10 mill. Rs
(198,4 Mio Euro) a year is intended to prevent bureaucratic
delays. The Foundation will fund centers of excellence and
support research in R&D institutes and universities.
(Hindustan
Times, 25.11.2005)

|
|
A 100 mill. Rs grant (18,9
Mio Euros) is given to the Indian Institute of Science,
Bangalore (IISc) by Finance minister Chidambaram. Goverdhan
Mehta, former IISc director, in an interview on this grant:
“Three components are needed to create a high class
institution: intellectual capital, environment for best
creativity and physical infrastructure. The IISc needs netter
labs, buildings and hostels for the students. Many people are
still unaware about the infrastructure at the IISc. In the
past five years, equipment worth 100 mill. Rs (18,9 Mio Euros)
have been inducted. Thrust areas will be nano sciences,
genomics, microelectromechanical systems and mathematics,
possibly also earth observation sciences.
(The
Times of India, 04.04.2006)

|
|
Science and Technology
Minister, Kapil Sibal, emphasized the need to create an
environment conducive to the growth of knowledge economy.
Releasing the reports on the Indian Semiconductor Industry
prepared by Frost & Sullivan in New Delhi, he said
semiconductor is to knowledge economy today what oil was to
industrial economy. The reports have projected a market of
over 36 billion dollars by 2015 for semiconductors in India.
(PRA:AD:NC-(8), 03.02.2006,
Summary available at
www.isaonline.org/documents/isafns-report-execsum.pdf)

|
|
India and South Korea
signed a MoU for cooperation in S&T on February 7th 2006. The
MoU, signed between India’s DST and Korea Industrial
Technology Foundation, aims at promoting technology innovation
and industrial cooperation. Technology transfer, co-hosting of
investment fairs and seminars are also envisaged.
(PTI, 07.02.2006)
|
|
8.
Guidelines on stem cell research
Guidelines on stem cell
research will released in the near future. The Indian Council
of Medical Research / Department of Biotechnology (DBT)
guidelines are in their final phase of preparation. The Indian
government is strongly promoting stem cell research in the
country. To this end, a stem cell society has been established
and the institutional infrastructure in institutes
strengthended, like All India Institute of Medical Sciences (AIIMS),
Post Graduate Institute (Chandigarh) and National Centre of
Brain Research (NBRC).
(PTI, Science Service, 16.-31.01.2006)

|
|
Science and Technology
Minister Kapil Sibal, summed up the proposals to make India a
biotechnology power in future. A committee of secretaries has
been constituted to work out modalities for the creation of a
single window - Authority and rationalization of the
legislative and regulatory regime. Included is a proposal to
award 25 special overseas fellowships for students doing
research in stem cell technology and nano biotechnology. The
Ministry would like to build strategic partnerships.
(Press Release, 14.03.2006, PRA:NC-(18)
The biotechnology industry is expected to grow again by more
than 30% like in the last years. K.K. Narayanan, president of
Association of Biotechnology Led Enterprises, Bangalore
(ABLE), said that the bioagro segment is expected to have the
highest growth. Biopharma will account for the majority of the
revenues. In 2004-2005 the BT industry zoomed past the $1
billion mark and the target by 2010 is $5 billion. This aim
would be achieved by increased foreign collaborations for
cost-effective innovations and Venture capital funding, added
Narayanan.
(The Economic Times, 22.03.2006)
The BT Industry was growing by 36.5 % this year and India is
among the top three in Asia-Pacific Biotech and among the top
12 globally.
(Business Standard, 05.04.2006)

|
|
During the inaugural
session on “Bio Parks” it was decided to set up a joint
working group of States which are interested in setting up
biotechnology parks for attracting life sciences companies and
R&D organisations. The number of parks will be increased to
ten by 2010. The two parks in Hyderabad and Pune had completed
renting or selling the created space. Another major decision
was to train the physicians in large numbers in the country
for clinical research and clinical trials.
(The Pioneer, 10.02.2006)

|
|
Bangalore Bio, India’s
biggest Biotech Show, has emerged as the global destination
for the entire Biotech fraternity to come together and explore
networking and business opportunities. The Biotech fraternity
leverages this exciting forum to showcase their products and
services, transform concepts into markets, explore investment
and partnering opportunities and forge new alliances in the
Biotech industry globally. Bangalore Bio is promoted by the
Deptartment of IT and Biotechnology, Government of Karnataka
and the Vision Group on Biotechnology.
(www.bangalorebio.com)

|
|
Delhi’s National Institute
of Immunology has identified five key genes that enable
Mycobacterium Tuberculosis to acquire the iron needed to grow
and promote the infection in humans. Experts say targeting
genes would help evolve better drugs to cure TB, which affects
15.4 million people world-wide. Observing that the expression
of some genes increased significantly in response to low iron
concentrations in the body, NII’s lead researcher Rajesh S.
Gokhale and his team identified a new siderophore core and
four new genes.
(PTI, Science Service, 1.-15.02.2006, The Hindu, 5.2.2006)

|
|
Indian scientists of The
Tata Institute of Fundamental Research in Bombay (TIFR)
achieved what has proved to be an illusive dream for Albert
Einstein and generations of physicists. They found an
experimental test for the quantum theory of gravity. Dr.
Pankaj Joshi is one of the Senior authors of the work
published in the “Physical Review Letters”. The work implies
that there could be no naked singularity when a star dies and
shrinks or when its stellar fuel is exhausted. Their work
showed that a collapsing star instead of turning into a black
hole or a naked singularity throws away all its matter in the
form of an explosive burst.
(The Pioneer, 08.02.2006)
|
|
The Phase I clinical trial
of a new conjugate vaccine against Meningitis bacteria has
been completed successfully and the next Phase would begin
later this year. The results were encouraging and opened
prospects to start Pivotal Phase II clinical trials in Gambia
and Mali later this year. If all goes well the new vaccine
could be introduced in Africa in the next three to four years
with a price of 40 cents per dose. The vaccine is being
developed through a public-private partnership between the
WHO, Serum Institute of India Ltd. (Pune) and Seattle-based
PATH. The new vaccine is expected to be more effective than
the existing ones because of its high immunogenicity in young
children.
(PTI Science Service, 01.-15.04.2006)

|
|
Indian Scientists have
announced a new concept that does not rely on natural or
enriched uranium but instead on thorium, that India has in
plenty, and a small amount of “seed” plutonium, which India
can recover from its spent fuel that has been accumulating
over the years. Called “A Thorium Breeder Reactor” (ATBR) it
has been evolved by scientists of the Bhabha Atomic Research
Centre (BARC) in Mumbai and has already attracted
international attention. One of the unique features of the
ATBR concept is loading of thorium oxide fuel rods in
specially designed “flux trap” or fissile breeding zones. The
BARC scientists say that there is no reactor design, fast or
thermal, which gives a continuous fissile growth within a span
of single fuel cycle. The ATBR idea will play a key role in
harnessing the energy from the large deposits of thorium in
India.
(PTI Service,
16.-28.02.2006)

|
|
Indian remote sensing
satellite (IRS) has shown the potential for mapping the stress
field of the earth’s crust that will help to predict areas
where powerful earthquakes are most likely. Prof. Ramesh Singh
of the IIT Kanpur has reported his work in the “Geophysical
Research Letter” published by American Geological Society. As
a test, they used the Bhuj earthquake in Gujarat from 2001.
The study has clearly shown changes in the stress direction
after the main earthquake. It produced large surface
deformations that could be easily mapped using remote sensing
data. Future satellite study of lineaments may yield further
data on stress field orientation and add to the existing World
Stress Map.
(PTI Science Service, 16.-28-02-2006)

|
|
Indian scientists have
cultured primitive human nervous system cells from foetuses
for AIDS study. Dr. Pankaj Seth form the National Brain
Research Centre (NBRC), near New Delhi, said that they have
been successful in isolating and maintaining purified cell
populations of human fetal brain-derived CNS progenitor cells.
The system is aimed to be used as a tool to investigate
HIV-induced neuropathogenesis. The scientists have also been
successful in inducing pathological conditions in these cells
with the help of HIV -1 virus particle and certain virus
proteins like “gp120” and “tat”. In November two
interdisciplinary centers for stem cell research and tissue
engineering - one each in New Delhi and Pune has been taken
up. (PTI, Science
Service, 1.-15.02.2006)

|
|
People's genes could help
determine how likely they are to become ill after being
exposed to arsenic, according to research in the current issue
of the International Journal of Cancer. The study, led by
Ashok Giri of the Indian Institute of Chemical Biology (IICB)
in Kolkatta, is the first to link a specific gene to people's
susceptibility to arsenic poisoning - a major public health
problem in parts of South Asia.
Giri's team studied more than 400 people in West Bengal,
India, where arsenic levels in drinking water can be 5-80
times above the WHO’s safe limit. They found that people
lacking a gene called GSTM1 were less likely to have the skin
lesions that are among the commonest symptoms of arsenic
poisoning.
In India and neighbouring Bangladesh, more than 100 million
people are at risk of arsenic poisoning. Over 300,000 people
in West Bengal have symptoms of exposure, ranging from lesions
to cancers of the skin and internal organs.
(www.SciDev.net,
27.03.2006, Link to full abstract of paper in the
International Journal of Cancer, 118, 2470 (2006))

|
|
19.
Science and Technology education in India
India is fast emerging as a
Knowledge Economy. McKinsey Global Institute estimates that
India has 14 million young university graduates; this is 1.5
times the size of China’s and almost twice that of the United
States. Every year 2.5 million new graduates are added to this
pool. Some facts and figures from the survey:
-
ICFDC.com presents
highlights of the report
-
¼ of graduates in science
-
engineering education has
highest growth, pool of 1 million engineers
-
India has a workforce of
376 million out of which 40.2 million (11%) could be
classified as Human Resource in Science and Technology
(Sapra India Bulletin,
December 2005)
|
|
According to the Indian
High Commissioner Kamalesh Sharma, the number of Indian
students studying in the UK has gone up from 3,800 five years
ago to 18,000 last year, despite the steep hike in the fees.
He also pointed out that out of the 21,500 work permits issued
last year for software engineers by the UK, 85 per cent were
from India. Lord Navnit Dholakia, Deputy leader of the Liberal
Democrats in the House of Lords said that now the biggest
problem for the UK is how to stop the students from going back
to India.
(PTI, 07.02.2006)
According to the German Academic
Exchange Service, 4259 Indian students are currently
studying in Germany. Among the European Member States,
Germany has the second highest number of Indian students,
after the UK.
|
|
The Indian Institute of
Technology (IIT) Roorkee has already zeroed on Noida, near
Delhi, to locate its new campus. Though the attempt by Indian
Institute of Management (IIM) Bangalore to open a campus in
Singapore had ran into trouble with the Ministry of Human
Resource Development, IIT expansion plans have the full
backing of the Ministry. One of the directors said that
instead of opening a campus abroad, the IITs are keen to
expand within India. All IITs will start new programs, also
five-year integrated MA programs in different social science
streams (humanities, policy research, etc.). The IITs are also
enhancing coordination among themselves.
(The Indian Express, 16.02.2006)

|
|
The Indian government has
decided to upgrade 20 National Institutes of Technology (NITs)
into technical universities by the “National Institutes of
Technology Bill 2006”. They will be more autonomous and will
be placed under the administrative concept of the Ministry of
Human Resource Development.
(Hindustan Times, 24.03.2006)

|
|
SThe Indian Government has
signed a MoU with the University of California Systems. Both
sides have agreed to spend about 10 million dollars per year
on projects carried out in areas such as biomedicine,
molecular biology, drug designing, mobile telephony,
nanotechnology, energy, material sciences, marine systems,
global warming and water management.
(PTI Science Service, 01.-15.04.2006)

|
|
The National Center for
Biological Sciences, Bangalore (NCBS) is the first Indian
research institution to get funds for joint research programs
from the Japan Science and Technology Agency (JST). A joint
project on membrane mechanism is set up and the project will
get $4 million from JST. 30 researchers from both sides will
be involved, NCBS will spend an equal amount. JST is thinking
about opening an office in New Delhi.
(Biospectrum, August
2005)

|
|
IIT Mumbai and IISC
Bangalore are setting up a Centre of Excellence in
Nanotechnology, funded by the Ministry of Communication and
Information Technology. The total cost of 100 mill. Rs (18,9
Mio Euro) spread over five years is equally shared by both the
institutions. The IIT Mumbai will focus on the devices and
circuits aspects and the IISC will focus more on the materials
aspects of nanoelectronics. It is the first joint program
between two leading academic institutes. This way about 200
trained personnel will be produced every year. The two major
benefits are the considerable cost saving and the
complementary expertise of the two teams effectively used.
(PTI Science Service, 16.-31.03.2006)
|
|
Each year since 1951, Nobel
Prize winners in Chemistry, Physics, Physiology or Medicine
have been meeting in Lindau with students from around the
world. The Department of Science and Technology (DST) has been
sending a group of students/ young researchers to these
meetings, since 2001. It is planned to send a group of Indian
Students and Scientists to the 56th Meeting of Nobel Laureates
during June 25-30, 2006. The German Research Foundation (DFG)
as well as the Max Planck Society offer a supplementary
program for the carefully selected students after the meeting.
(DST, 06.02.2006)

|
|
The Max Planck Institute of
Economics, Jena and the Indian Institute of Science (IISc),
Bangalore have organized a workshop on Entrepreneurship,
Innovation and Economic Growth.
Entrepreneurship has been recognized as a major determinant of
economic growth in most developed countries.
(Max Planck Institute of Economics, Jena)
|
|
C.N.R. Rao, chairman of the
Prime Minister’s Science Advisory Council said that Indian
industries need more scientists. The S&T Ministry (DST) has
therefore offered research facilities to scientists and
engineers from all over the world – with a fellowship of Rs.
50.000 a month and a contingency fund of Rs. 500.000 (9470
Euros) a year. The Srinivasa Ramanujan Fellowship does not
have limiting factors like age or citizenship. This is
intended primarily as an invitation for Indian scientists
working abroad to return home.
(Hindustan Times, 25.11.2005)

|
|
Wolverhampton University,
one of the leading Universities in the UK opened an office in
New Delhi to attract Indian students for higher studies. Lord
Swraj Paul, non-residential Indian industrialist and
Chancellor of the University, formally launched the office on
February 22nd.
(PTI, 10.02.2006)

|
|
NASSCOM, the premier trade
body and voice of the IT software and service industry in
India, has sharpened its focus on the Indian IT market through
its Domestic IT Market committee.
A recent NASSCOM-IDC study has emphasised the huge potential
of the domestic IT market.
In view to accelerating domestic growth, the NASSSCOM Domestic
IT market committee includes a representation from the IT
industry (Microsoft, Oracle, TCS, Wipro, HCL, Tally, NISG and
IBM), corporate sector (Bharti Televentures, ICICI Bank,
Hitech Gears, Reliance Infocomm, Shoppers Stop, Tata Steel,
SBI and Jumpstartup) and research institutes (IIT Chennai and
IIT Mumbai). The committee is chaired by Mr. Ramadorai, CEO,
Tata Consultancy Services and Chairman NASSCOM, and this is
indicative of the importance that NASSCOM attaches to the
domestic market. (IndiaTimes
News Network, 04.04.2006,
www.economictimes.indiatimes.com)

|
|
Renowned Indian scientist
Goverdhan Mehta has become the second Indian to be elected as
the President of the International Council for Science (ICSU)
on October 21, 2005 in Suzhou, China. Another Indian
scientist, Prof. Anupam Varma from the Indian Agricultural
Institute, has been elected to the ICSU as chairman of the
Regional Committee for Asia and the Pacific. Mehta, a former
Director of the Indian Institute of Science and Vice
Chancellor of the University of Hyderabad, is an expert in the
chemistry of complex natural and non natural products.
(PTI Science Service, 1.-15.12.2005)

|
|
Continuing the trend of
consolidation in the global generics business, India's pharma
major, Dr Reddy's Laboratories has announced a 570 mill. USD
acquisition of Betapharm, Germany's fourth largest generics
company. Dr Reddy's outbid world's largest generics company,
Teva, drug giant Sanofi-Aventis and India's largest pharma
company, Ranbaxy to buy Betapharm.
Commenting on the acquisition, Dr Anji Reddy, chairman, Dr
Reddy's Laboratories, said, "We see our investment in
Betapharm as a key strategic initiative towards becoming a
mid-sized global pharmaceutical company with strong presence
in all key pharmaceutical markets. Betapharm has created a
strong growth platform and is well positioned for the future
and we are looking forward to partner with them in building a
strategic presence in Europe."
Dr Wolfgang Niedermaier, CEO of Betapharm said, "Dr Reddy's
impressive pipeline of generic and innovative products and its
high quality standards combined with competitive manufacturing
infrastructure will help further develop our position in the
German market and offer an entry platform for the European
market.
(BioSpectrum, 15.03.2006,
www.biospectrumindia.com)

|
|
This newsletter has been prepared by the
Science Section of the Embassy of the Federal Republic of
Germany, New Delhi. Texts of articles from science magazines
and newspapers have been edited for their length and are
partly based on information from the Embassy. No
responsibility for the content of the articles is accepted.
|
|
|